Core Laboratory Infectious Disease

Infectious Disease — Hepatitis

Contact a Rep HTML

Request more information about Roche's Hepatitis Assay.

Please complete the form below to speak with a Roche representative.

 
 
 
 
Overview

Elecsys® Anti-HCV II assay

The CDC recommends HCV testing for anyone born between 1945-1965.1

The first-line test to aid in the diagnosis of HCV, delivering reliable, accurate results for patient-focused decision-making and a more efficient workflow.

100% sensitivity for all genotypes

Excellent seroconversion sensitivity for early detection of infection

High specificity in clinical routine testing

Improve workflow with ready-to-use liquid reagents, lot calibration and 31 days of on-board stability

HCV is putting baby boomers at risk

Many don’t know they’re infected.

Up to 3.9 million people in the U.S. have chronic HCV.2

People born during 1945-1965 are 5x more likely to have HCV.3

HCV is the No. 1 cause of liver transplants and a leading cause of liver cancer.3

To learn more about our entire portfolio,
Download the Elecsys® Hepatitis Assays brochure.

Infectious Disease Portfolio

References:

  1. Viral Hepatitis. Centers for Disease Control and Prevention. https://www.cdc.gov/hepatitis/hcv/guidelinesc.htm(accessed May 31, 2017).
  2. “Hepatitis C FAQs for the Public.” Centers for Disease Control and Prevention. https://www.cdc.gov/hepatitis/hcv/cfaq.htm#cFAQ21(accessed August 17, 2017).
  3. Hepatitis C: Why people born from 1945-1965 should get tested.” Centers for Disease Control and Prevention https://www.cdc.gov/knowmorehepatitis/index.htm(accessed August 17, 2017).
Resources

Outside of Pepper mode, this text will be replaced by the resource cards.

Contact Us

Outside of Pepper mode, this text will be replaced by the content added in the above "Contact a Rep HTML" code editor.